Home Cart Sign in  
Chemical Structure| 896657-58-2 Chemical Structure| 896657-58-2

Structure of MGH-CP1
CAS No.: 896657-58-2

Chemical Structure| 896657-58-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

MGH-CP1 is a potent and orally active TEAD2 and TEAD4 auto-palmitoylation inhibitor with anti-tumor activity. By inhibiting the palmitoylation of TEAD proteins, it reduces Myc expression and induces apoptosis, showing potential for cancer treatment.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of MGH-CP1

CAS No. :896657-58-2
Formula : C20H24N4OS
M.W : 368.50
SMILES Code : O=C(NC1=CC=C(C23CC4CC(C3)CC(C4)C2)C=C1)CSC5=NC=NN5
MDL No. :MFCD07361635
InChI Key :UUKXOVBCMOZQNC-UHFFFAOYSA-N
Pubchem ID :2993112

Safety of MGH-CP1

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of MGH-CP1

Hippo

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HEK293A cells 10 μM 24 hours Inhibition of TEAD-YAP transcriptional activity PMC9643419
ACHN cells Concentration-dependent Inhibited cell proliferation PMC11933345
Huh7 cells 10 μM 24 hours Inhibition of tumor sphere formation PMC9643419
MDA-MB-231 cells 10 μM 24 hours Inhibition of cell migration PMC9643419

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Lats1/2 double-knockout mice Intraperitoneal injection 75 mg/kg Once daily for 21 days Inhibition of liver overgrowth PMC9643419
Mouse Pax8-rtTA;tet-on-YAPS127A mice Intraperitoneal injection 75 mg/kg Twice daily for seven days Inhibited YAP1-induced MDSC accumulation and tumor development PMC11933345

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.71mL

0.54mL

0.27mL

13.57mL

2.71mL

1.36mL

27.14mL

5.43mL

2.71mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories